概述
                - 
                        货号 DHC38202 
- 
                                表达系统 Mammalian Cells
- 
                                种属反应性 Human
- 
                                宿主 Human
- 
                                同种型 Fusion - [FLT1 (fms-related tyrosine kinase 1, vascular endothelial growth factor receptor 1, VEGFR-1, VEGFR, FLT, FRT, vascular permeability factor receptor) domain 2 fragment (132-232) - KDR (kinase insert domain receptor, vascular endothelial growth factor receptor 2, VEGFR2, VEGF-R2, FLK1, CD309) domain 3 fragment (227-327) - FGFR1 (fibroblast growth factor receptor 1, FLT2, KAL2) domains 2 and 3 fragment (150-361)]2 - IGHG1 Fc (Fragment constant)
- 
                                靶标 bFGF, FGF2, Basic fibroblast growth factor, HBGF-2, FGFB, FGF-2, Heparin-binding growth factor 2, Fibroblast growth factor 2, Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A
- 
                                浓度 1 mg/ml
- 
                                内毒素水平 Please contact with the lab for this information.
- 
                                纯度 >95% as determined by SDS-PAGE.
- 
                                纯化方式 Protein A/G purified from cell culture supernatant.
- 
                                Accession号 P09038 & P15692
- 
                                克隆号 Eflimrufusp Alfa 
- 
                                应用 Research Grade Biosimilar
- 
                                状态 Liquid
- 
                                保存溶液 0.01M PBS, pH 7.4.
- 
                                稳定性和存储 Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
- 
                                别名 RC-28,RC28-E,VF-28,VF-Trap-8, CAS: 2363779-14-8 
图片
                参考文献
                评价
                








 
                 
            